News about Global Pharma

Glenmark Pharmaceuticals Introduces Latanoprost Ophthalmic Solution

Glenmark’s Latanoprost Ophthalmic Solution, 0.005 percent (0.05 mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug, Xalatan®2 Ophthalmic Solution, 0.005 percent of Upjohn US 2 LLC.

Global Pharma | 18/02/2025 | By Aishwarya |  285

Innate Pharma Secures FDA Granted BTD for Lacutamab

The BTD is granted based on Phase 1 study results as well as results from the Phase 2 TELLOMAK study, where lacutamab demonstrated encouraging efficacy and a favorable safety profile in heavily pretreated, post-mogamulizumab patients with advanced Sézary syndrome.

Global Pharma | 18/02/2025 | By Aishwarya |  307

3Z Pharmaceuticals Announces Publication of Transformative Study in Neuropsychopharmacology

3Z Pharmaceuticals announced the publication of a transformative study in Neuropsychopharmacology, highlighting compelling scientific evidence that positions the mechanisms engaged by amlodipine, an L-type calcium channel blocker (LTCC), as a foundation for a novel therapy for ADHD.

Global Pharma | 17/02/2025 | By Manvi |  297

Grindeks Continues to Strengthen its Global Presence by Entering New Export Markets

This year, for the first time, Grindeks products will be delivered to Panama. The company's export markets already include countries such as Chile, Mexico, Australia, Singapore, the Philippines, and most of Europe.

Global Pharma | 17/02/2025 | By Manvi |  236

IASO Bio Receives Hong Kong's DOH Acceptance of NDA for Equecabtagene Autoleucel

This treatment is indicated for patients with relapsed and/or refractory multiple myeloma (R/R MM) who have received three or more prior lines of therapies.

Global Pharma | 17/02/2025 | By Aishwarya |  358

Innovent Gets Second Fast Track Designation from FDA for IBI363

This designation applies to the treatment of unresectable, locally advanced, or metastatic squamous non-small cell lung cancer (sqNSCLC) that has progressed following anti-PD-(L)1 immune checkpoint inhibitor therapy and platinum-based chemotherapy.

Global Pharma | 17/02/2025 | By Aishwarya |  327

Tiger Wound Care Acquires Novo Health Care Service's Encore Surgical HealPACK Solutions

HealPACK is a convenience pack of premium line of surgical dressing products trusted by physicians nationwide. HealPACK comes with a specifically development HealPACK app that supports the prescription and insurance verification process needed to order the product.

Global Pharma | 15/02/2025 | By Manvi |  410

American Injectables Announces Strategic Leadership Appointments

Travis Allen, who has been instrumental in American Injectables' development since its founding, has been appointed CEO and Board Director. Paul Campanelli, former CEO of Endo International and Par Pharmaceutical, will transition to the role of Executive Chairman, while Kimberlee Steele, MD of North America at SHL Medical, joins as a new Board Member.

Global Pharma | 15/02/2025 | By Manvi |  158

Nexus Pharmaceuticals Secures FDA Approval for Tacrolimus Injection

Tacrolimus Injection 5 mg/mL (Single-Dose Vial) in a 10-pack will be launching soon.

Global Pharma | 15/02/2025 | By Aishwarya |  454

Alcami Appoints Tori E. Arens as President-Drug Product

In this role, Arens will lead the cGMP drug product manufacturing operations at Alcami.

Global Pharma | 15/02/2025 | By Aishwarya |  314